Michael Baker

Michael Baker serves as the Chief Executive Officer and Managing Director of Arovella Therapeutics since 2020 and holds the position of Non-Executive Director at Radiopharm Theranostics from April 2021 to March 2024. Previously, Baker was an Investment Manager at Bioscience Managers Pty Ltd (2017-2019), a Project Manager at Hexima Limited (2014-2017), and a Post-Doctoral Researcher at the Bio21 Institute (2013-2014). Academic accomplishments include a Doctor of Philosophy in Biochemistry from La Trobe University, where Baker also received the Nancy Millis award for the most outstanding thesis in 2010. Educational qualifications include an M.B.A. from Melbourne Business School and participation in an exchange program at UCLA Anderson School of Management focusing on business strategy in emerging markets.